Radioligand Therapy Beyond Neuroendocrine Tumours: Dosimetry, Supply Chain and Access. Translational Medicine & Therapeutics Journal, [S. l.], v. 2, n. 2, p. 64–73, 2023. DOI: 10.5281/zenodo.22649084. Disponível em: https://inkwise.org/index.php/TMTJ/article/view/84. Acesso em: 5 nov. 2026.